Searched for: in-biosketch:yes
person:at570
Human blastocysts of normal and abnormal karyotypes display distinct transcriptome profiles
Licciardi, Frederick; Lhakhang, Tenzin; Kramer, Yael G; Zhang, Yutong; Heguy, Adriana; Tsirigos, Aristotelis
Unveiling the transcriptome of human blastocysts can provide a wealth of important information regarding early embryonic ontology. Comparing the mRNA production of embryos with normal and abnormal karyotypes allows for a deeper understanding of the protein pathways leading to viability and aberrant fetal development. In addition, identifying transcripts specific for normal or abnormal chromosome copy number could aid in the search for secreted substances that could be used to non-invasively identify embryos best suited for IVF embryo transfer. Using RNA-seq, we characterized the transcriptome of 71 normally developing human blastocysts that were karyotypically normal vs. trisomic or monosomic. Every monosomy and trisomy of the autosomal and sex chromosomes were evaluated, mostly in duplicate. We first mapped the transcriptome of three normal embryos and found that a common core of more than 3,000 genes is expressed in all embryos. These genes represent pathways related to actively dividing cells, such as ribosome biogenesis and function, spliceosome, oxidative phosphorylation, cell cycle and metabolic pathways. We then compared transcriptome profiles of aneuploid embryos to those of normal embryos. We observed that non-viable embryos had a large number of dysregulated genes, some showing a hundred-fold difference in expression. On the contrary, sex chromosome abnormalities, XO and XXX displayed transcriptomes more closely mimicking those embryos with 23 normal chromosome pairs. Intriguingly, we identified a set of commonly deregulated genes in the majority of both trisomies and monosomies. This is the first paper demonstrating a comprehensive transcriptome delineation of karyotypic abnormalities found in the human pre-implantation embryo. We believe that this information will contribute to the development of new pre-implantation genetic screening methods as well as a better understanding of the underlying developmental abnormalities of abnormal embryos, fetuses and children.
PMID: 30297919
ISSN: 2045-2322
CID: 3334642
Classification and Mutation Prediction from Non-Small Cell Lung Cancer Histopathology Images Using Deep Learning [Meeting Abstract]
Ocampo, P.; Moreira, A.; Coudray, N.; Sakellaropoulos, T.; Narula, N.; Snuderl, M.; Fenyo, D.; Razavian, N.; Tsirigos, A.
ISI:000454014501440
ISSN: 1556-0864
CID: 3575142
BET bromodomain inhibition cooperates with PD-1 blockade to facilitate antitumor response in Kras-mutant non-small cell lung cancer
Adeegbe, Dennis O; Liu, Shengwu; Hattersley, Maureen; Bowden, Michaela; Zhou, Chensheng W; Li, Shuai; Vlahos, Raven; Grondine, Michael; Dolgalev, Igor; Ivanova, Elena; Quinn, Max M; Gao, Peng; Hammerman, Peter S; Bradner, James E; Diehl, J Alan; Rustgi, Anil K; Bass, Adam J; Tsirigos, Aristotelis; Freeman, Gordon J; Chen, Huawei; Wong, Kwok-Kin
KRAS mutation is present in approximately 30% of human lung adenocarcinomas. Although recent advances in targeted therapy have shown great promise, effective targeting of KRAS remains elusive, and concurrent alterations in tumor suppressors render KRAS-mutant tumors even more resistant to existing therapies. Contributing to the refractoriness of KRAS-mutant tumors are immunosuppressive mechanisms, such as increased presence of suppressive regulatory T cells (Tregs) in tumors and elevated expression of the inhibitory receptor PD-1 on tumor-infiltrating T cells. Treatment with BET bromodomain inhibitors is beneficial for hematologic malignancies, and they have Treg-disruptive effects in a non-small cell lung cancer (NSCLC) model. Targeting PD-1 inhibitory signals through PD-1 antibody blockade also has substantial therapeutic impact in lung cancer, although these outcomes are limited to a minority of patients. We hypothesized that the BET bromodomain inhibitor JQ1 would synergize with PD-1 blockade to promote a robust antitumor response in lung cancer. In the present study, using Kras+/LSL-G12D; Trp53L/L (KP) mouse models of NSCLC, we identified cooperative effects between JQ1 and PD-1 antibody. The numbers of tumor-infiltrating Tregs were reduced and activation of tumor-infiltrating T cells, which had a T-helper type 1 (Th1) cytokine profile, was enhanced, underlying their improved effector function. Furthermore, lung tumor-bearing mice treated with this combination showed robust and long-lasting antitumor responses compared to either agent alone, culminating in substantial improvement in the overall survival of treated mice. Thus, combining BET bromodomain inhibition with immune checkpoint blockade offers a promising therapeutic approach for solid malignancies such as lung adenocarcinoma.
PMID: 30087114
ISSN: 2326-6074
CID: 3226582
Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning
Coudray, Nicolas; Ocampo, Paolo Santiago; Sakellaropoulos, Theodore; Narula, Navneet; Snuderl, Matija; Fenyö, David; Moreira, Andre L; Razavian, Narges; Tsirigos, Aristotelis
Visual inspection of histopathology slides is one of the main methods used by pathologists to assess the stage, type and subtype of lung tumors. Adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC) are the most prevalent subtypes of lung cancer, and their distinction requires visual inspection by an experienced pathologist. In this study, we trained a deep convolutional neural network (inception v3) on whole-slide images obtained from The Cancer Genome Atlas to accurately and automatically classify them into LUAD, LUSC or normal lung tissue. The performance of our method is comparable to that of pathologists, with an average area under the curve (AUC) of 0.97. Our model was validated on independent datasets of frozen tissues, formalin-fixed paraffin-embedded tissues and biopsies. Furthermore, we trained the network to predict the ten most commonly mutated genes in LUAD. We found that six of them-STK11, EGFR, FAT1, SETBP1, KRAS and TP53-can be predicted from pathology images, with AUCs from 0.733 to 0.856 as measured on a held-out population. These findings suggest that deep-learning models can assist pathologists in the detection of cancer subtype or gene mutations. Our approach can be applied to any cancer type, and the code is available at https://github.com/ncoudray/DeepPATH .
PMID: 30224757
ISSN: 1546-170x
CID: 3300392
Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning
Coudray, Nicolas; Ocampo, Paolo Santiago; Sakellaropoulos, Theodore; Narula, Navneet; Snuderl, Matija; Fenyö, David; Moreira, Andre L; Razavian, Narges; Tsirigos, Aristotelis
Visual inspection of histopathology slides is one of the main methods used by pathologists to assess the stage, type and subtype of lung tumors. Adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC) are the most prevalent subtypes of lung cancer, and their distinction requires visual inspection by an experienced pathologist. In this study, we trained a deep convolutional neural network (inception v3) on whole-slide images obtained from The Cancer Genome Atlas to accurately and automatically classify them into LUAD, LUSC or normal lung tissue. The performance of our method is comparable to that of pathologists, with an average area under the curve (AUC) of 0.97. Our model was validated on independent datasets of frozen tissues, formalin-fixed paraffin-embedded tissues and biopsies. Furthermore, we trained the network to predict the ten most commonly mutated genes in LUAD. We found that six of them-STK11, EGFR, FAT1, SETBP1, KRAS and TP53-can be predicted from pathology images, with AUCs from 0.733 to 0.856 as measured on a held-out population. These findings suggest that deep-learning models can assist pathologists in the detection of cancer subtype or gene mutations. Our approach can be applied to any cancer type, and the code is available at https://github.com/ncoudray/DeepPATH .
ORIGINAL:0014811
ISSN: 1556-0864
CID: 4662042
MOSAIC BLASTOCYSTS DIAGNOSED WITH NEXT GENERATION SEQUENCING (NGS) HAVE UNIQUE TRANSCRIPTOMIC PROFILES DIFFERENT FROM THOSE OF EUPLOID OR ANEUPLOID EMBRYOS. [Meeting Abstract]
Maxwell, S. M.; Lhakhang, T.; Kramer, Y. G.; Zhang, Y.; Heguy, A.; Tsirigos, A.; Grifo, J. A.; Licciardi, F.
ISI:000448713600189
ISSN: 0015-0282
CID: 3493792
Oncogenic hijacking of the stress response machinery in T cell acute lymphoblastic leukemia
Kourtis, Nikos; Lazaris, Charalampos; Hockemeyer, Kathryn; Balandrán, Juan Carlos; Jimenez, Alejandra R; Mullenders, Jasper; Gong, Yixiao; Trimarchi, Thomas; Bhatt, Kamala; Hu, Hai; Shrestha, Liza; Ambesi-Impiombato, Alberto; Kelliher, Michelle; Paietta, Elisabeth; Chiosis, Gabriela; Guzman, Monica L; Ferrando, Adolfo A; Tsirigos, Aristotelis; Aifantis, Iannis
Cellular transformation is accompanied by extensive rewiring of many biological processes leading to augmented levels of distinct types of cellular stress, including proteotoxic stress. Cancer cells critically depend on stress-relief pathways for their survival. However, the mechanisms underlying the transcriptional initiation and maintenance of the oncogenic stress response remain elusive. Here, we show that the expression of heat shock transcription factor 1 (HSF1) and the downstream mediators of the heat shock response is transcriptionally upregulated in T cell acute lymphoblastic leukemia (T-ALL). Hsf1 ablation suppresses the growth of human T-ALL and eradicates leukemia in mouse models of T-ALL, while sparing normal hematopoiesis. HSF1 drives a compact transcriptional program and among the direct HSF1 targets, specific chaperones and co-chaperones mediate its critical role in T-ALL. Notably, we demonstrate that the central T-ALL oncogene NOTCH1 hijacks the cellular stress response machinery by inducing the expression of HSF1 and its downstream effectors. The NOTCH1 signaling status controls the levels of chaperone/co-chaperone complexes and predicts the response of T-ALL patient samples to HSP90 inhibition. Our data demonstrate an integral crosstalk between mediators of oncogene and non-oncogene addiction and reveal critical nodes of the heat shock response pathway that can be targeted therapeutically.
PMCID:6082694
PMID: 30038221
ISSN: 1546-170x
CID: 3206552
ETV1 activates a rapid conduction transcriptional program in rodent and human cardiomyocytes
Shekhar, Akshay; Lin, Xianming; Lin, Bin; Liu, Fang-Yu; Zhang, Jie; Khodadadi-Jamayran, Alireza; Tsirigos, Aristotelis; Bu, Lei; Fishman, Glenn I; Park, David S
Rapid impulse propagation is a defining attribute of the pectinated atrial myocardium and His-Purkinje system (HPS) that safeguards against atrial and ventricular arrhythmias, conduction block, and myocardial dyssynchrony. The complex transcriptional circuitry that dictates rapid conduction remains incompletely understood. Here, we demonstrate that ETV1 (ER81)-dependent gene networks dictate the unique electrophysiological characteristics of atrial and His-Purkinje myocytes. Cardiomyocyte-specific deletion of ETV1 results in cardiac conduction abnormalities, decreased expression of rapid conduction genes (Nkx2-5, Gja5, and Scn5a), HPS hypoplasia, and ventricularization of the unique sodium channel properties that define Purkinje and atrial myocytes in the adult heart. Forced expression of ETV1 in postnatal ventricular myocytes (VMs) reveals that ETV1 promotes a HPS gene signature while diminishing ventricular and nodal gene networks. Remarkably, ETV1 induction in human induced pluripotent stem cell-derived cardiomyocytes increases rapid conduction gene expression and inward sodium currents, converting them towards a HPS phenotype. Our data identify a cardiomyocyte-autonomous, ETV1-dependent pathway that is responsible for specification of rapid conduction zones in the heart and demonstrate that ETV1 is sufficient to promote a HPS transcriptional and functional program upon VMs.
PMCID:6028599
PMID: 29967479
ISSN: 2045-2322
CID: 3185592
Determining EGFR and STK11 mutational status in lung adenocarcinoma histopathology images using deep learning [Meeting Abstract]
Coudray, Nicolas; Moreira, Andre L; Sakellaropoulos, Theodore; Fenyo, David; Razavian, Narges; Tsirigos, Aristotelis
ORIGINAL:0014812
ISSN: 1538-7445
CID: 4662052
Notch Signaling Facilitates In Vitro Generation of Cross-Presenting Classical Dendritic Cells
Kirkling, Margaret E; Cytlak, Urszula; Lau, Colleen M; Lewis, Kanako L; Resteu, Anastasia; Khodadadi-Jamayran, Alireza; Siebel, Christian W; Salmon, Hélène; Merad, Miriam; Tsirigos, Aristotelis; Collin, Matthew; Bigley, Venetia; Reizis, Boris
The IRF8-dependent subset of classical dendritic cells (cDCs), termed cDC1, is important for cross-priming cytotoxic T cell responses against pathogens and tumors. Culture of hematopoietic progenitors with DC growth factor FLT3 ligand (FLT3L) yields very few cDC1s (in humans) or only immature "cDC1-like" cells (in the mouse). We report that OP9 stromal cells expressing the Notch ligand Delta-like 1 (OP9-DL1) optimize FLT3L-driven development of cDC1s from murine immortalized progenitors and primary bone marrow cells. Co-culture with OP9-DL1 induced IRF8-dependent cDC1s with a phenotype (CD103+ Dec205+ CD8α+) and expression profile resembling primary splenic cDC1s. OP9-DL1-induced cDC1s showed preferential migration toward CCR7 ligands in vitro and superior T cell cross-priming and antitumor vaccination in vivo. Co-culture with OP9-DL1 also greatly increased the yield of IRF8-dependent CD141+ cDC1s from human bone marrow progenitors cultured with FLT3L. Thus, Notch signaling optimizes cDC generation in vitro and yields authentic cDC1s for functional studies and translational applications.
PMCID:6063084
PMID: 29925006
ISSN: 2211-1247
CID: 3157652